Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shanghai Ankon Raises $100 Million to Market Pill-like Endoscopy Device

publication date: Aug 15, 2017

Shanghai Ankon Technologies raised $100 million in venture capital to market NaviCam, a swallow-able device about the size of a pill, for imaging the gastric track to diagnose stomach cancer and other gastric problems. The 15-minute minimally-invasive procedure provides doctors with an inside look of a patient's gastric track. Ankon wants to expand into new markets and develop similar systems for early diagnosis of other diseases. The round included investors SBCVC, Dazhong Investment, Youshi Capital and Tongsheng Capital. More details....



Share this with colleagues:





Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here